Dividend investors should not overlook investment opportunities despite the S&P 500’s low 1.2% yield, as attractive options exist in the healthcare sector, including Kenvue, Medtronic, and Pfizer. Kenvue, spun off from Johnson & Johnson, focuses on the over-the-counter market, while J&J continues its operations in pharmaceuticals and medical devices.
Want More Context? 🔎
